Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Common antibiotic could boost stroke recovery, major trial launches

NCT ID NCT07237048

First seen Nov 19, 2025 · Last updated Apr 30, 2026 · Updated 20 times

Summary

This study tests whether adding the antibiotic minocycline to standard stroke care helps people with moderate strokes recover better. About 1,164 adults will be randomly assigned to receive either minocycline pills for five days plus usual care, or usual care alone. Researchers will measure neurological function and disability at discharge, 30 days, and 90 days after the stroke to see if minocycline improves outcomes and reduces complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Maimonides Medical Center

    RECRUITING

    Brooklyn, New York, 11219, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.